相关实验视频

Updated: Sep 11, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

对脂质和脂质修饰标对状大动脉狭窄的因果作用的遗传洞察:孟德尔的随机研究

Chengrong Wu¹, Qian Pu², Yalin Zou¹

¹Reproductive Center, Guiyang Maternal and Child Care Hospital, Guiyang, 550000, Guizhou, China.

Scientific reports

|August 13, 2025

概括

动脉硬化 (CAVS) 与高总胆固醇和LDL胆固醇有因果关系. 抑制PCSK9,一种药物标,可能会降低CAVS风险,ApoB和Lp (a) 发挥中介作用.

科学领域:

心血管遗传学心血管遗传学
药物基因组学药物基因组学
动脉样硬化研究动脉样硬化研究

背景情况:

动脉狭窄症 (CAVS) 是一个日益严重的全球健康问题,药物治疗有限.
脱脂症是疑似CAVS的危险因素,但其因果作用和脂质修饰药物的疗效仍然不确定.
了解CAVS的遗传基础对于开发有效的治疗策略至关重要.

研究的目的:

调查遗传代理脂质特征与CAVS风险之间的因果关系.
通过使用孟德尔随机化来评估12种脂质修饰药物点在CAVS治疗中的治疗潜力.
探索PCSK9-CAVS通路中的潜在调解因素,包括脂蛋白a (Lp(a)) 和阿波利波蛋白B (ApoB).

主要方法:

使用孟德尔随机化 (MR) 来评估脂质特征和药物点对CAVS的因果关系.
从全球脂质遗传学联盟 (GLGC) 和来自TARGET和FinnGen联盟的CAVS总结级数据中获取遗传变异.
进行了局部化,调解和敏感性分析,以验证研究结果并确定调解者.

主要成果:

总胆固醇和LDL胆固醇被证实是CAVS的独立因果风险因素.
对PCSK9抑制的基因模仿表明,CAVS风险显著降低 (OR=0.63).
ApoB和Lp (a) 分别介导了PCSK9对CAVS风险总影响的55.9%和4.5%.

结论:

总胆固醇和LDL胆固醇是动脉结缩的已确立因果因素.
基因代理抑制PCSK9是一种有前途的治疗策略,可以降低CAVS风险.
ApoB和Lp (a) 是将PCSK9与CAVS病变发生联系的途径的重要媒介.

关键词:

卡尔西夫大动脉狭窄症这就是LDL-C.脂质的个人资料脂质的个人资料门德尔的随机化在PCSK9中我们的eQTL是eQTL.在pQTLTL中,pQTL是指pQTL.

更多相关视频

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

相关概念视频

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...